Log in

Sign up

Vijay Mahant

President and CEO at Renova Therapeutics

Vijay Mahant is the President and CEO of Renova Therapeutics, working in gene therapy for Congestive Heart Failure, NASH, and Type-2 Diabetes. Prior to this role, Mahant served as the Founder and CEO of MediLite Diagnostika, focusing on ultra-sensitive technology for molecular and immuno-diagnostics. Vijay holds a MS and PhD from Loughborough University.

Links

Org chart

Timeline

  • President and CEO

    September 1, 2021 - present

Related people

BUSINESS

EVERY ORG CHART

Access the worlds's biggest network of public org charts

Learn more
A panel showing how The Org can help with contacting the right person.